Evaluation of the prognostic importance of c-myc and bcl-2 expressions and the presence of epstein-barr virus in classical hodgkin lymphoma
Author(s) -
Aydan Kılıçarslan,
Vedia Ozturk,
Aysun Şentürk Yıkılmaz,
Mehmet Doğan,
Mesut Akyol
Publication year - 2018
Publication title -
turkish journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.305
H-Index - 14
eISSN - 1309-5730
pISSN - 1018-5615
DOI - 10.5146/tjpath.2018.01430
Subject(s) - in situ hybridization , classical hodgkin lymphoma , lymphoma , immunohistochemistry , staining , pathology , medicine , significant difference , virus , hodgkin lymphoma , biology , immunology , gene expression , gene , genetics
Although classical Hodgkin lymphoma (cHL) has a relatively good prognosis, it also entails different treatment responses and involves patients who have different clinical courses. Our aim was to investigate c-Myc, Bcl-2 and EBV biomarkers in cHL and their relationship with the IPS score.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom